PRME
Prime Medicine, Inc.
2.90$
-5.5%
vs. previous close
Closing price · As of: Sep 25, 2026
Statements
Income Statement
All figures as a percentage of revenue in the same period.
Tick rows to compare them in a chart (up to 4)
| Line item | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|
| – | 100.0% | – | 100.0% | – | 100.0% | 100.0% | |
| – | 57.2% | – | 230.6% | – | 205.4% | 158.1% | |
| – | 42.8% | – | -230.6% | – | 100.0% | -58.1% | |
| – | 57.2% | – | 1,664.6% | – | 5,205.8% | 3,468.0% | |
| – | 60.7% | – | 572.3% | – | 1,681.6% | 1,130.1% | |
| – | 60.7% | – | 2,236.9% | – | 6,887.4% | 4,440.0% | |
| – | -17.9% | – | -2,236.9% | – | -6,787.4% | -4,498.1% | |
| – | 196.9% | – | 232.8% | – | – | – | |
| – | -29.6% | – | -2,356.4% | – | -6,566.6% | -4,342.4% | |
| – | 35.8% | – | -18.2% | – | – | – | |
| – | -65.5% | – | -2,338.2% | – | -6,566.6% | -4,342.4% | |
| – | -17.1% | – | -2,313.7% | – | -6,361.2% | -4,226.2% |
Data as of: September 25, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)
Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.